Kimia Biosciences Closes Trading Window for Q2/H1 FY27 Results

Kimia Biosciences Ltd has announced the closure of its trading window for dealing in the company's equity shares. This closure is effective from October 1, 2026, and will remain in effect for 48 hours after the declaration of the Unaudited Financial Results for the quarter and half-year ending September 30, 2026. The decision aligns with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window is closed for promoters, directors, designated persons, and their immediate relatives. The specific date for the Board of Directors' meeting to approve these financial results will be communicated separately.